Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Uniunea Europeană - bulgară - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - грипен вирус повърхностните антигени (хемаглутинин и невраминидазния) на щам a/Виетнам/1194/2004 (Н5n1) - influenza, human; immunization; disease outbreaks - Ваксини - Активна имунизация срещу подтип h5n1 на вируса на грипа А. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Therafiu Cold And Cough 500 mg/10 mg/200 mg syrop Bulgaria - bulgară - Изпълнителна агенция по лекарствата

therafiu cold and cough 500 mg/10 mg/200 mg syrop

novartis consumer health gmbh - ДРУГИ ЛЕКАРСТВА СТУДЕНА КОМБИНАЦИЯ - 500 mg/10 mg/200 mg syrop

Otrivin Extra 0,5 mg/ml + 0,6 mg/ml nasal spray, Solution Bulgaria - bulgară - Изпълнителна агенция по лекарствата

otrivin extra 0,5 mg/ml + 0,6 mg/ml nasal spray, solution

novartis consumer health gmbh - Ксилометазолин - 0,5 mg/ml + 0,6 mg/ml nasal spray, solution